An aberrant form of human CHROMOSOME 22 characterized by translocation of the distal end of chromosome 9 from 9q34, to the long arm of chromosome 22 at 22q11. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia (LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE).
See also reference (FX) in Slovak
proteíny fúzne, onkogénové
See also reference (FX) in English
Oncogene Proteins, Fusion
Links
(21) - ARTICLES
(3) - MeSH descriptor
(6) - CiBaMed
(4) - BOOKS
subject heading
Number of the records: 1
openseadragon
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.